SI
Sofinnova Investments Portfolio holdings
AUM
$1.47B
This Quarter Return
+9.08%
1 Year Return
+17.43%
3 Year Return
+337.79%
5 Year Return
+424.38%
10 Year Return
–
AUM
$1.47B
AUM Growth
+$1.47B
(-10%)
Cap. Flow
-$134M
Cap. Flow
% of AUM
-9.12%
Top 10 Holdings %
Top 10 Hldgs %
65.38%
Holding
60
New
12
Increased
13
Reduced
12
Closed
9
Top Buys
| 1 |
Eli Lilly
LLY
|
$47.1M |
| 2 |
Intuitive Surgical
ISRG
|
$38.2M |
| 3 |
Biogen
BIIB
|
$36.9M |
| 4 |
Merck
MRK
|
$25.3M |
| 5 |
PTC Therapeutics
PTCT
|
$25M |
Top Sells
| 1 |
Sanofi
SNY
|
$95.2M |
| 2 |
CINC
CinCor Pharma, Inc. Common Stock
CINC
|
$74.6M |
| 3 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$54.5M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$45.3M |
| 5 |
AstraZeneca
AZN
|
$41.6M |
Sector Composition
| 1 | Healthcare | 99.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Fulcrum Therapeutics
FULC
$353M
| – | – |
-631,411
| Closed | -$4.6M |
|
52
NovoCure
NVCR
$1.35B
| – | – |
0
| – | – |
|
53
Arcus Biosciences
RCUS
$1.24B
| – | – |
-314,811
| Closed | -$6.51M |
|
|
54
Sanofi
SNY
$122B
| – | – |
-1,965,475
| Closed | -$95.2M |
|
55
SPDR S&P 500 ETF Trust
SPY
$656B
| – | – |
0
| – | – |
|
56
United Therapeutics
UTHR
$17.7B
| – | – |
-89,207
| Closed | -$24.8M |
|
|
57
Vertex Pharmaceuticals
VRTX
$102B
| – | – |
-156,989
| Closed | -$45.3M |
|
|
OBSV
58
DELISTED
ObsEva SA Ordinary Shares
OBSV
| – | – |
-4,749,623
| Closed | -$689K |
|
|
CINC
59
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
| – | – |
-6,073,949
| Closed | -$74.6M |
|